HOWARD E. GENDELMAN, M.D.
Dr. Howard E. Gendelman is the David T. Purtilo Distinguished Professor, Department of Pathology and Microbiology and Internal Medicine and Director of the Center for Neurovirology and Neurodegenerative Disorders (CNND) at the University of Nebraska Medical Center. Under Dr. Gendelman’s guidance, the research of the CNND has made bold and sustained contributions towards understand how alterations in mononuclear phagocyte function may lead to damage of brain cells. Most recently Dr. Gendelman and his group have begun to examine how these exact cells may be allowed to encourage regeneration of damaged brain cells in neurodestructive diseases such as Alzheimer’s disease, Parkinson’ disease, multiple sclerosis and AIDS –related dementia
He obtained a Bachelor’s degree in Natural Sciences and Russian Studies from Muhlenberg College and his MD from Pennsylvania State University. He completed a residency in internal medicine at Montefiore Hospital and a fellowship in infectious diseases at Johns Hopkins University. He joined the University of Nebraska Medical Center in 1993 after occupying faculty positions at Johns Hopkins, the NIH, and Walter Reed Hospital and Research Institute. He retired from the US Army Reserve with the rank of Lieutenant Colonel.
Dr. Gendelman has authored over 174 publications and edited three books and serves on numerous editorial boards, as well as national and international scientific committees. He has been an invited lecturer for more than 200 scientific seminars and symposia. He is the recipient of numerous honors, including the Henry L. Moses Award in Basic Science from the Albert Einstein College of Medicine; the Carter-Wallace Fellow for Distinction in AIDS Research; the 1999 Pennsylvania State University Alumni Fellow; 1997 the David T. Purtilo Distinguished Professorship of Pathology and Microbiology, the 1998 Award for Outstanding Achievement University of Nebraska Medical Center and most recently received a J. William Fulbright Scholar for research, studying regeneration at the Weizmann Institute of Science in Rehovot, Israel in the fall of 2000.